Johnsen H E, Kjaer M, Skinhøj P, Jacobsen N
Epidemiafdeling M, Rigshospitalet, København.
Ugeskr Laeger. 1991 Jan 7;153(2):101-4.
During 1980-1988 bone marrow transplantation was performed in 14 patients with acquired severe aplastic anemia. Twelve of these patients had HLA identical and two patients incompatible family donors. Two patients died before marrow engraftment. Twelve patients engrafted 12-30 days after marrow transplantation with continued normal marrow function. The actuarial probability for long term survival was found to be 67% after HLA identical allogeneic sibling marrow transplantation. The longest time of observation was 9 years and the patient is still alive. All deaths occurred during the first six months posttransplant. It is concluded that the serious prognosis for patients with SAA has improved if the patients have the possibility for allogeneic HLA identical family donor transplantation.
1980年至1988年期间,对14例获得性重型再生障碍性贫血患者进行了骨髓移植。其中12例患者有 HLA 配型相合的家族供者,2例患者有 HLA 配型不相合的家族供者。2例患者在骨髓植入前死亡。12例患者在骨髓移植后12 - 30天植入,骨髓功能持续正常。HLA 配型相合的异基因同胞骨髓移植后长期生存的精算概率为67%。观察最长时间为9年,该患者仍存活。所有死亡均发生在移植后的前六个月。结论是,如果患者有可能接受 HLA 配型相合的家族供者移植,重型再生障碍性贫血患者的严重预后情况有所改善。